Lopez-Rodriguez R., Perez-Pampin E., Marquez A., Blanco F.J., Joven B., Carreira P., Ferrer M.A., Caliz R., Valor L., Narvaez J., Cañete J.D., Del Carmen Ordoñez M., Manrique-Arija S., Vasilopoulos Y., Balsa A., Pascual-Salcedo D., Moreno-Ramos M.J., Alegre-Sancho J.J., Navarro-Sarabia F., Moreira V., Garcia-Portales R., Raya E., Magro-Checa C., Martin J., Gomez-Reino J.J., Gonzalez A. (2018)
Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, ...